You have 9 free searches left this month | to do more

bendamustine

Bendamustine is a drug used to treat Chronic Lymphocytic Leukemia, Lymphoma, Mantle Cell Lymphoma, and other conditions. Bendamustine is being actively studied in 62 studies and prior, has been studied in 80.

Top SponsorsTop SitesTop Investigators
Hoffmann-La RocheSamsung Medical CenterJonathon Cohen
M.D. Anderson Cancer CenterCentre Henri BecquerelAdam Olszewski
German CLL Study GroupColumbia University Medical CenterAntonio Pinto
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
W
Active, not recruiting
  • Mantle Cell Lymphoma
  • Bendamustine
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-05-21
May 21, 2021
U
Completed
  • Multiple Myeloma
  • Berne, Switzerland
    Department for Medical Oncology University Hospital/Inselspital
2021-07-29
Jul 29, 2021
N
Recruiting
  • Hairy Cell Leukemia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022
U
Recruiting
  • Mantle Cell Lymphoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
2022-03-07
Mar 7, 2022
Y
Not yet recruiting
  • PTLD
  • +8 more
  • New Haven, Connecticut
  • +1 more
2021-10-28
Oct 28, 2021
W
Recruiting
  • Relapsed T-Cell Lymphoma
  • +2 more
  • CPI 613
  • Bendamustine
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
2021-08-27
Aug 27, 2021
W
Active, not recruiting
  • Mantle Cell Lymphoma
  • Bendamustine
  • +7 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-02-02
Feb 2, 2022
S
Not yet recruiting
  • Relapsed, Refractory, Multiple Myeloma
  • Guangzhou, Please Select, China
    Sun Yat-sen University Cancer Center
2021-02-17
Feb 17, 2021
P
Active, not recruiting
  • Indolent Non-hodgkin Lymphoma
  • München, Bavaria, Germany
    Klinikum der Universität München
2021-07-23
Jul 23, 2021
U
Active, not recruiting
  • Lymphoid Leukemia
  • +2 more
  • Bendamustine
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin
2021-10-07
Oct 7, 2021
A
Completed
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Innsbruck, Tirol, Austria
  • +6 more
2022-02-15
Feb 15, 2022
U
Terminated
  • Lymphoid Leukemia
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-07-20
Jul 20, 2021
U
Completed
  • Lymphoma, Non-Hodgkin
  • Lymphoma
  • Davis, California
  • +2 more
2021-04-21
Apr 21, 2021
D
Completed
  • Lymphoma, Follicular
  • Bendamustine
  • +2 more
  • Scarborough, Maine
  • +3 more
2021-04-27
Apr 27, 2021
P
Recruiting
  • Mantle Cell Lymphoma
  • Urbana, Illinois
  • +10 more
2021-12-21
Dec 21, 2021
F
Terminated
  • Lymphatic Diseases
  • Brentuximab Vedotin
  • Bendamustine
  • Bologna, BO, Italy
  • +4 more
2021-05-26
May 26, 2021
A
Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +5 more
  • Providence, Rhode Island
    Rhode Island Hospital and The Miriam Hospital
2021-07-19
Jul 19, 2021
G
Active, not recruiting
  • Chronic Lymphocytic Leucemia
  • Bendamustine
  • +2 more
  • Cologne, Germany
    German CLL Study Group
2021-12-13
Dec 13, 2021
S
Active, not recruiting
  • Non-Hodgkin's Lymphoma
  • Bendamustine
  • +6 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
2021-06-03
Jun 3, 2021
G
Active, not recruiting
  • Chronic Lymphocytic Leucemia
  • Bendamustine
  • +2 more
  • Cologne, Germany
    German CLL Study Group
2021-08-23
Aug 23, 2021
U
Recruiting
  • Acute Lymphoblastic Leukemia
  • +12 more
  • Tucson, Arizona
    The University of Arizona Cancer Center
2021-05-10
May 10, 2021